Healthcare provider profile · identity verified

Brian V Phillips, MD

Family Practice · EAST GRAND RAPIDS, MI · NPI 1558365163

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	672	211
Atorvastatin Calcium	Atorvastatin Calcium	590	181
Losartan Potassium	Losartan Potassium	484	140
Levothyroxine Sodium	Levothyroxine Sodium	472	126
Amlodipine Besylate	Amlodipine Besylate	469	139
Omeprazole	Omeprazole	373	119
Metoprolol Succinate	Metoprolol Succinate	289	89
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	279	82
Tamsulosin Hcl	Tamsulosin Hcl	254	76
Pravastatin Sodium	Pravastatin Sodium	235	68
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	184	55
Pantoprazole Sodium	Pantoprazole Sodium	181	56
Gabapentin	Gabapentin	180	52
Metformin Hcl	Metformin Hcl	177	57
Lisinopril	Lisinopril	176	52
Metformin Hcl Er	Metformin Hcl	170	57
Escitalopram Oxalate	Escitalopram Oxalate	161	47
Trazodone Hcl	Trazodone Hcl	136	43
Hydrochlorothiazide	Hydrochlorothiazide	135	42
Sertraline Hcl	Sertraline Hcl	132	38
Potassium Chloride	Potassium Chloride	124	38
Trulicity	Dulaglutide	122	19
Finasteride	Finasteride	118	36
Eliquis	Apixaban	116	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	108	27
Alprazolam	Alprazolam	101	40
Ezetimibe	Ezetimibe	101	35
Duloxetine Hcl	Duloxetine Hcl	95	30
Tramadol Hcl	Tramadol Hcl	95	36
Bupropion Xl	Bupropion Hcl	93	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	93	30
Allopurinol	Allopurinol	86	24
Glipizide Er	Glipizide	77	20
Fluticasone Propionate	Fluticasone Propionate	74	30
Carvedilol	Carvedilol	69	21
Furosemide	Furosemide	68	27
Jardiance	Empagliflozin	63	18
Albuterol Sulfate Hfa	Albuterol Sulfate	60	29
Prednisone	Prednisone	59	34
Fluoxetine Hcl	Fluoxetine Hcl	58	17
Montelukast Sodium	Montelukast Sodium	54	16
Lorazepam	Lorazepam	53	13
Methylprednisolone	Methylprednisolone	50	36
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	14
Lansoprazole	Lansoprazole	48	13
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	47	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	47	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	18
Propranolol Hcl Er	Propranolol Hcl	44	suppressed
Clonazepam	Clonazepam	43	16
Venlafaxine Hcl Er	Venlafaxine Hcl	43	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	12
Folic Acid	Folic Acid	41	12
Famotidine	Famotidine	40	11
Xarelto	Rivaroxaban	40	suppressed
Ipratropium Bromide	Ipratropium Bromide	39	13
Diclofenac Sodium	Diclofenac Sodium	38	13
Esomeprazole Magnesium	Esomeprazole Magnesium	37	suppressed
Lovastatin	Lovastatin	37	11
Mometasone Furoate	Mometasone Furoate	37	24
Simvastatin	Simvastatin	37	13
Cephalexin	Cephalexin	36	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	29
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Ozempic	Semaglutide	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	12
Meloxicam	Meloxicam	34	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	12
Mounjaro	Tirzepatide	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	15
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	12
Fenofibrate	Fenofibrate	30	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	28	suppressed
Celecoxib	Celecoxib	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Klor-Con M20	Potassium Chloride	28	suppressed
Pregabalin	Pregabalin	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	15
Divalproex Sodium	Divalproex Sodium	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Dulera	Mometasone/Formoterol	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Latanoprost	Latanoprost	21	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Amoxicillin	Amoxicillin	20	13
Meclizine Hcl	Meclizine Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	19	suppressed
Azithromycin	Azithromycin	19	14
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	14
Benazepril Hcl	Benazepril Hcl	18	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Diazepam	Diazepam	18	suppressed
Terbinafine Hcl	Terbinafine Hcl	18	11
Topiramate	Topiramate	18	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Cefuroxime	Cefuroxime Axetil	13	11
Donepezil Hcl	Donepezil Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Testosterone	Testosterone	13	suppressed
Atenolol	Atenolol	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nystatin	Nystatin	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	12
Trimethoprim	Trimethoprim	12	suppressed
Fluconazole	Fluconazole	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error